Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication

NCT00562107 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.

NCT NCT00562107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00562107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication
Lead sponsor
LivaNova
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2007
Completion date
April 30, 2013
Enrollment
650 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

assess the benefits from the aaisafer/safer algorithm of symphony 2550 or replytm dr in a wide range of pacemaker patients.